文献速递妇科

直肠阴道深部浸润型子宫内膜异位症腹腔镜手术中靶向加压素注射的疗效:一项随机临床试验

Efficacy of Targeted Vasopressin Injection at the Rectovaginal Deep Infiltrating Endometriosis During Laparoscopic Surgery : A Randomized Clinical Trial.
PubMed 文献 · J Minim Invasive Gynecol · 2026-07-30

本研究为患者盲法随机临床试验,纳入2023年1月至2024年1月期间20-50岁、III/IV期直肠阴道深部浸润型子宫内膜异位症(DIE)女性,比较腹腔镜手术中靶向注射加压素(20单位/mL稀释于300mL生理盐水)与等量生理盐水对手术时间、出血、血红蛋白下降、并发症及术者满意度的影响。

核心结论

  • 直肠阴道DIE病灶靶向注射加压素可简化腹腔镜分离,减少手术时间和出血,改善解剖可视化,并减少手术并发症。

研究设计与样本

  • 患者盲法随机临床试验,2023年1月至2024年1月在一所三级大学医院开展。
  • 纳入20至50岁、DIE III/IV期女性。
  • 干预组注射20单位/mL加压素(稀释于300mL生理盐水)至直肠阴道DIE结节,对照组注射等量生理盐水至相同部位。

主要发现

  • 两组人口学特征除原发不孕外无显著差异。
  • 术后痛经和性交痛:干预组分别降至2例和2例,对照组分别降至2例和1例。

关键数值与推荐

  • 干预组加压素剂量为20单位/mL,稀释于300mL生理盐水。

临床怎么用

  • 在直肠阴道DIE腹腔镜手术中,可考虑靶向注射加压素以缩短手术时间、减少出血和并发症,并改善术者满意度。

局限性

  • 研究存在局限性,可能影响 findings,需要未来更全面的研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To evaluate the efficacy of targeted vasopressin injection at the rectovaginal deep infiltrating endometriosis (DIE) during laparoscopic dissection. DESIGN: Patient-blinded randomized clinical trial from January 2023 to January 2024. SETTING: Tertiary university hospital. PATIENTS: Women aged 20 to 50 years with DIE stage III/IV. INTERVENTIONS: In laparoscopic surgery, in the intervention group, 20 units/mL of vasopressin, diluted in 300 mL of normal saline, was precisely injected into the rectovaginal DIE nodules). In the control group, an equal volume of saline was injected at the same sites. MEASUREMENTS: Surgical time, intraoperative bleeding, hemoglobin drop, surgical complications, and surgeon satisfaction were measured as the study outcomes. RESULTS: There was no significant difference between the two groups in demographic characteristics, except for primary infertility. The results of the present study showed that in laparoscopic surgery for pelvic endometriosis, the injection of Vasopressin significantly reduced the duration of the surgery (p = .016), decreased bleeding and hemoglobin drop (p = .034), surgery complications (p = .041), and increased surgeon satisfaction (p <.001) about the dissection of endometriosis tissue and anatomical differentiation of the pelvic organs compared to saline injection. In addition, 30 and 14 patients in the intervention group and 23 and 8 patients in the control group, respectively, complained of dysmenorrhea and dyspareunia. The findings showed that postoperative dysmenorrhea and dyspareunia in the intervention group decreased to 2 and 2 patients, respectively, and in the control group, they decreased to 2 and 1 patients, respectively. CONCLUSION: Targeted vasopressin injection at the rectovaginal DIE lesion as a simple way facilitates laparoscopic dissection by reducing operative time and bleeding, improving anatomical visualization, and decreasing surgical complications. The study's limitations may have affected the findings; future comprehensive studies are needed to confirm our findings.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Tanha FD, Feizabad E, Salehi F, et al. Efficacy of Targeted Vasopressin Injection at the Rectovaginal Deep Infiltrating Endometriosis During Laparoscopic Surgery : A Randomized Clinical Trial. J Minim Invasive Gynecol. 2026. PMID: 42532203. doi:10.1016/j.jmig.2026.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。